ISPE, ILF are involved, American and Asian regulators meeting in Japan, China
Tuesday, May 15th, 2012Tampa, Florida, USA (PRWEB) May 14, 2012
ISPE continue its mission to provide a neutral ground for pharmaceutical industry professionals and regulators to discuss industry issues ISPE Affiliate meeting in Japan and China in the past months. Events attended by officials from the U.S., FDA, PIC / S, soup, MHRA, China’s State Food and Drug Administration (Public Administration) and other agencies to discuss key issues with leading pharmaceutical industry experts and groups such as the International Management Forum (ILF) .as an independent pharmaceutical industrial association ISPE is dedicated to increasing industry through meetings, such as prisoners in Japan and China, said at ISPEs President and CEO Nancy Berg. These meetings were extremely successful in providing a forum for regulators and industry from the two largest pharmaceutical markets in the world to engage in face-to-face dialogue about real problems and solutions
key themes of the meeting of the International Partnership in Japan, which took place on 12 April 13, including international harmonization and the consequences of globalization, especially in connection with counterfeiting and lack of medicines. Meeting of China, which took place on 16 April 17, aims to implement and enforce the new guidelines GMP of China, and includes open and honest discussion with the public administration.
These meetings have also noted the first meeting of the Asia-Pacific ILF, a global advisory group of pharmaceutical production managers, design, engineering and quality of the ISPE, and is dedicated to providing leadership and management of critical technical issues faced by the industry. ILF discussed the global strategy of positioning (GPS), an instrument with regulators and industry leaders in both meetings. Joint meetings with industry leaders and representatives from Chinese and Japanese authorities, health and fruitful cooperation, said Wu Shmukler, ILF, and advisor to the president, global manufacturing and supply of Bristol-Myers Squibb. GPS is a welcome and important contribution has been shared. We see, GPS is an important initiative to support the industry’s progress in this area.
ILFs GPS document is available for review and comment on the site of ILF. ILFs The next meeting will be held at a joint FDA / ISPE conference to review with cGMP in Baltimore, Maryland, USA on June 3.
For more information on upcoming meetings and conferences, visit the ISPE http://www.ISPE.org/Events.
About ISPE
ISPE, the International Society for Pharmaceutical Engineering, is a nonprofit pharmaceutical company 22 000 professionals in 90 countries that use the experience to create high-quality, cost-effective solutions to GMP. Founded in 1980, ISPE offers online learning opportunities for audiences around the world and has worldwide headquarters in Tampa, Florida, United States and its European headquarters in Brussels, Belgium, Asia-Pacific office in Singapore and its newest office in Shanghai, China. Visit http://www.ISPE.org news and information about additional community
clear = “all”
